Filing Details
- Accession Number:
- 0001255627-19-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-11 16:20:12
- Reporting Period:
- 2019-03-07
- Accepted Time:
- 2019-03-11 16:20:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Vermillion Inc. | VRML | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1255627 | David Schreiber | C/O Vermillion, Inc. 12117 Bee Caves Rd, Bldg 3 Ste 100 Austin TX 78738 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2019-03-07 | 30,000 | $1.00 | 137,405 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
